BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1225 related articles for article (PubMed ID: 32970989)

  • 1. SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2.
    Clausen TM; Sandoval DR; Spliid CB; Pihl J; Perrett HR; Painter CD; Narayanan A; Majowicz SA; Kwong EM; McVicar RN; Thacker BE; Glass CA; Yang Z; Torres JL; Golden GJ; Bartels PL; Porell RN; Garretson AF; Laubach L; Feldman J; Yin X; Pu Y; Hauser BM; Caradonna TM; Kellman BP; Martino C; Gordts PLSM; Chanda SK; Schmidt AG; Godula K; Leibel SL; Jose J; Corbett KD; Ward AB; Carlin AF; Esko JD
    Cell; 2020 Nov; 183(4):1043-1057.e15. PubMed ID: 32970989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Utility of Native MS for Understanding the Mechanism of Action of Repurposed Therapeutics in COVID-19: Heparin as a Disruptor of the SARS-CoV-2 Interaction with Its Host Cell Receptor.
    Yang Y; Du Y; Kaltashov IA
    Anal Chem; 2020 Aug; 92(16):10930-10934. PubMed ID: 32678978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites.
    Qiao B; Olvera de la Cruz M
    ACS Nano; 2020 Aug; 14(8):10616-10623. PubMed ID: 32806067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2.
    Clausen TM; Sandoval DR; Spliid CB; Pihl J; Painter CD; Thacker BE; Glass CA; Narayanan A; Majowicz SA; Zhang Y; Torres JL; Golden GJ; Porell R; Garretson AF; Laubach L; Feldman J; Yin X; Pu Y; Hauser B; Caradonna TM; Kellman BP; Martino C; Gordts PLSM; Leibel SL; Chanda SK; Schmidt AG; Godula K; Jose J; Corbett KD; Ward AB; Carlin AF; Esko JD
    bioRxiv; 2020 Jul; ():. PubMed ID: 32699853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of SARS-CoV-2 Cell Entry Inhibitors by Drug Repurposing Using
    Choudhary S; Malik YS; Tomar S
    Front Immunol; 2020; 11():1664. PubMed ID: 32754161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor.
    Yang J; Petitjean SJL; Koehler M; Zhang Q; Dumitru AC; Chen W; Derclaye S; Vincent SP; Soumillion P; Alsteens D
    Nat Commun; 2020 Sep; 11(1):4541. PubMed ID: 32917884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACE2-Independent Interaction of SARS-CoV-2 Spike Protein with Human Epithelial Cells Is Inhibited by Unfractionated Heparin.
    Partridge LJ; Urwin L; Nicklin MJH; James DC; Green LR; Monk PN
    Cells; 2021 Jun; 10(6):. PubMed ID: 34200372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular docking study of potential phytochemicals and their effects on the complex of SARS-CoV2 spike protein and human ACE2.
    Basu A; Sarkar A; Maulik U
    Sci Rep; 2020 Oct; 10(1):17699. PubMed ID: 33077836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural and Recombinant SARS-CoV-2 Isolates Rapidly Evolve
    Shiliaev N; Lukash T; Palchevska O; Crossman DK; Green TJ; Crowley MR; Frolova EI; Frolov I
    J Virol; 2021 Oct; 95(21):e0135721. PubMed ID: 34406867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.
    Zhai X; Sun J; Yan Z; Zhang J; Zhao J; Zhao Z; Gao Q; He WT; Veit M; Su S
    J Virol; 2020 Jul; 94(15):. PubMed ID: 32404529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2.
    Liu Z; Xiao X; Wei X; Li J; Yang J; Tan H; Zhu J; Zhang Q; Wu J; Liu L
    J Med Virol; 2020 Jun; 92(6):595-601. PubMed ID: 32100877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and simulation of fully glycosylated molecular models of ACE2-Fc fusion proteins and their interaction with the SARS-CoV-2 spike protein binding domain.
    Bernardi A; Huang Y; Harris B; Xiong Y; Nandi S; McDonald KA; Faller R
    PLoS One; 2020; 15(8):e0237295. PubMed ID: 32756606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of the ACE2-SARS-CoV-2/SARS-CoV spike protein interface reveal unique mechanisms.
    Ali A; Vijayan R
    Sci Rep; 2020 Aug; 10(1):14214. PubMed ID: 32848162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis of receptor recognition by SARS-CoV-2.
    Shang J; Ye G; Shi K; Wan Y; Luo C; Aihara H; Geng Q; Auerbach A; Li F
    Nature; 2020 May; 581(7807):221-224. PubMed ID: 32225175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal.
    Fantini J; Chahinian H; Yahi N
    Int J Antimicrob Agents; 2020 Aug; 56(2):106020. PubMed ID: 32405156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broad and Differential Animal Angiotensin-Converting Enzyme 2 Receptor Usage by SARS-CoV-2.
    Zhao X; Chen D; Szabla R; Zheng M; Li G; Du P; Zheng S; Li X; Song C; Li R; Guo JT; Junop M; Zeng H; Lin H
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32661139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection.
    Braz HLB; Silveira JAM; Marinho AD; de Moraes MEA; Moraes Filho MO; Monteiro HSA; Jorge RJB
    Int J Antimicrob Agents; 2020 Sep; 56(3):106119. PubMed ID: 32738306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor.
    Zhao P; Praissman JL; Grant OC; Cai Y; Xiao T; Rosenbalm KE; Aoki K; Kellman BP; Bridger R; Barouch DH; Brindley MA; Lewis NE; Tiemeyer M; Chen B; Woods RJ; Wells L
    Cell Host Microbe; 2020 Oct; 28(4):586-601.e6. PubMed ID: 32841605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coevolution, Dynamics and Allostery Conspire in Shaping Cooperative Binding and Signal Transmission of the SARS-CoV-2 Spike Protein with Human Angiotensin-Converting Enzyme 2.
    Verkhivker G
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33158276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the genetic variation in ACE2 on the structural recognition by the novel coronavirus (SARS-CoV-2).
    Guo X; Chen Z; Xia Y; Lin W; Li H
    J Transl Med; 2020 Aug; 18(1):321. PubMed ID: 32831104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.